Health Care Monthly Monitor

Insights, Innovation and Impact

September 2021

This timely update provides insights into health care sector stock performance and social impact themes related to U.N. Sustainable Development Goal 3 (Good Health and Well-Being).

Market Insights 

September was a difficult month for equities, as rising interest rates and various uncertainties weighed on markets. Economic growth estimates worldwide were revised down to reflect apparent slowdowns in the U.S. and Chinese economies. Meanwhile, inflation rose, and the U.S. Federal Reserve appeared to lay the groundwork for cutting back its bond holdings and raising short-term interest rates in 2022. Investors faced additional uncertainty from the default of China’s largest real estate developer, Evergrande Holdings, and political grandstanding in Washington about raising the federal debt limit. Against this backdrop, non-U.S. developed market equities generally outperformed U.S., small-company stocks beat large and value outperformed growth.  

Our Health Care Impact Themes

New or Innovative Treatments for Diseases Including Cancer
Access to Medicines and Health Care Services
New Solutions for Lowering Health Care Costs
Enhancing the Productivity of Medical Equipment, Services and Software

Positive Developments on COVID Cases and Treatments

Peaks in the rates of new COVID-19 cases and deaths came in mid- to late-August and declined in September, according to World Health Organization data. 

Progress on Managing Diabetes  

We think it’s also important to mark significant progress in treating diabetes, a disease that afflicts more than 450 million people worldwide

Company in Focus

Insulet is an innovative company that specializes in diabetes treatment. The company’s disposable, wearable patch pumps provide automated, continuous delivery of insulin.

Download the Full Report

Investment return and principal value of security investments will fluctuate. The value at the time of redemption may be more or less than the original cost. Past performance is no guarantee of future results.

The opinions expressed are those of American Century Investments (or the portfolio manager) and are no guarantee of the future performance of any American Century Investments' portfolio. This material has been prepared for educational purposes only. It is not intended to provide, and should not be relied upon for, investment, accounting, legal or tax advice.

References to specific securities are for illustrative purposes only, and are not intended as recommendations to purchase or sell securities. Opinions and estimates offered constitute our judgment and, along with other portfolio data, are subject to change without notice.